Wobble uridine modifications-a reason to live, a reason to die?! - PubMed (original) (raw)

Review

Wobble uridine modifications-a reason to live, a reason to die?!

Raffael Schaffrath et al. RNA Biol. 2017.

Abstract

Wobble uridines (U34) are generally modified in all species. U34 modifications can be essential in metazoans but are not required for viability in fungi. In this review, we provide an overview on the types of modifications and how they affect the physico-chemical properties of wobble uridines. We describe the molecular machinery required to introduce these modifications into tRNA posttranscriptionally and discuss how posttranslational regulation may affect the activity of the modifying enzymes. We highlight the activity of anticodon specific RNases that target U34 containing tRNA. Finally, we discuss how defects in wobble uridine modifications lead to phenotypes in different species. Importantly, this review will mainly focus on the cytoplasmic tRNAs of eukaryotes. A recent review has extensively covered their bacterial and mitochondrial counterparts. 1.

Keywords: Anticodon wobble base; RNases; mRNA translation; protein homeostasis; stress responses; tRNA modification.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Modifications of wobble uridines (U34). (A) Uridine derivatives that can be found at the wobble position (U34) in anticodons of cytoplasmic tRNAs from eukaryotes. Modifications to uridine are indicated in red. (structures taken from Modomics21). Abbreviations: ncm5U: 5-carbamoylmethyluridine; ncm5Um: 5-carbamoylmethyl-2’-O-methyluridine; mcm5U: 5-methoxycarbonyl-methyluridine; mcm5s2U: 5-methoxycarbonylmethyl-2-thiouridine. (B) Detail of the structure of the anticodon stem loop (ASL) of human tRNAUUULys3. mcm5s2U is highlighted by spheres. Sulfur (yellow), carbon (green), oxygen (red). Note that the nucleobases are arranged in a stacking confirmation (The structure is based on PDB 1FIR).

Figure 2.

Figure 2.

Model of the URM1 pathway and the Elongator complex. Schematic representation of the 2 pathways cooperating in mcm5s2U34 formation. In the URM1 pathway (left), sulfur is mobilized by Nfs1 with the help of Tum1. Uba4 activates Urm1, leading to a thiocarboxylate at Urm1's C-terminus, which acts as a sulfur carrier. Finally, the Ncs2•Ncs6 complex binds to and activates tRNA in the thiolation reaction and transfers the sulfur from Urm1 to uridine. The Elongator complex consists of twice Elp1-Elp6. Elp1 dimerizes via its C-terminus and acts as a platform for Elp2 and Elp3 binding in a wing-like structure. A ring of Elp4-Elp6 binds to one of the wings (Handedness is only partially represented in this model).

Figure 3.

Figure 3.

Phosphomodification of Elongator subunit Elp1. (A) Elp1 electrophoretic mobility shifts based on anti-HA Western blots are diagnostic for Elongator de-/phosphorylation. In the kti12 and the kinase-dead hrr25/kti14 mutants, hypophosphorylated forms of Elp1-HA accumulate while sit4 phosphatase mutants induce Elp1-HA hyperphosphorylation. Wild-type (wt) cells maintain both isoforms of Elp1-HA, which mediate sensitivity (S) to growth inhibition by the tRNase toxin zymocin (killer assay: lower panel; for details see text). Zymocin resistance (R) associates with Elp1 phosphorylation defects in kti12, hrr25/kti14 and sit4 mutants. (B) Elongator phosphorylation model. Kti12 interacts with Elongator (and kinase Hrr25) thereby potentially activating Elp1 phosphorylation. In support of this, Elp1 is found to be hypophosphorylated in kti12 and hrr25/kti14 cells (see A). PPase: protein phosphatase (Sit4); Kinase: Hrr25/Kti14.

Figure 4.

Figure 4.

Two models to explain phenotypes of U34 modification mutants. (A) Specific mRNA enriched in codons that depend on tRNA modifications are translated at lower rates. This leads to reduced levels of the protein encoded by this transcript triggering a loss-of-function phenotype. (B) Ribosomes slow down when translating codons that depend on tRNA modifications. The slowdown perturbs the optimized equilibrium between speed of protein synthesis and protein folding. The increased rate of protein stress leads to a systemic failure in protein homeostasis and the aggregation of endogenous proteins that associates with it in a toxic gain-of-function scenario. This can either affect viability of the cells directly or by changing cellular signaling (Street signs with “30” indicate slow speed of ribosomes).

References

    1. Armengod ME, Meseguer S, Villarroya M, Prado S, Moukadiri I, Ruiz-Partida R, Garzón MJ, Navarro-González C, Martínez-Zamora A. Modification of the wobble uridine in bacterial and mitochondrial tRNAs reading NNA/NNG triplets of 2-codon boxes. RNA Biol 2015; 11:1495-507; http://dx.doi.org/10.4161/15476286.2014.992269 - DOI - PMC - PubMed
    1. Jackman JE, Alfonzo JD. Transfer RNA modifications: nature's combinatorial chemistry playground. WIREs RNA 2012; 4:35-48; PMID:23139145; http://dx.doi.org/10.1002/wrna.1144 - DOI - PMC - PubMed
    1. Helm M, Alfonzo JD. Posttranscriptional RNA Modifications: playing metabolic games in a cell's chemical Legoland. Chem Biol 2014; 21:174-85; PMID:24315934; http://dx.doi.org/10.1016/j.chembiol.2013.10.015 - DOI - PMC - PubMed
    1. Grosjean H, Breton M, Sirand-Pugnet P, Tardy F, Thiaucourt F, Citti C, Barré A, Yoshizawa S, Fourmy D, de Crécy-Lagard V, et al.. Predicting the Minimal Translation Apparatus: Lessons from the Reductive Evolution of Mollicutes. PLoS Genet 2014; 10:e1004363; PMID:24809820; http://dx.doi.org/10.1371/journal.pgen.1004363 - DOI - PMC - PubMed
    1. Hutchison CA, Chuang R-Y, Noskov VN, Assad-Garcia N, Deerinck TJ, Ellisman MH, Gill J, Kannan K, Karas BJ, Ma L, et al.. Design and synthesis of a minimal bacterial genome. Science 2016; 351:aad6253; PMID:27013737; http://dx.doi.org/10.1126/science.aad6253 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources